Both adaptive and innate immune memory responses have been described in gamma delta T cells, yet the mechanisms, the ligands and the gamma delta T cell subsets generating memory responses have remain ...

Current approaches in bioengineering are synthesized and methods for their implementation are suggested for the induction and modulation of trained immunity in the treatment of human diseases.

Bacteria have evolved sophisticated antiphage systems that halt phage replication upon detecting specific phage triggers. Identifying phage triggers is crucial to our understanding of immune signaling ...

Despite their size, insects have sophisticated immune systems. They lack an adaptive immune system, which is a common feature in mammals, but they compensate with a highly efficient innate immune ...

The biological mechanisms by which CRP exerts its effects on the immune system is discussed.

Major U.S. airlines want the Federal Aviation Administration to delay by two years the requirement set to take effect in August that new passenger airplanes have a secondary barrier to the flight ...

A decades-old TB vaccine turned cancer therapy may unlock new immunotherapies by reprogramming immune cell development in the bone marrow.

The "innate" immune system offers rapid, general defenses against new threats, whereas the "adaptive" immune system prepares responses tailored to threats it has previously encountered.

Primary barriers to getting physical health care include the unavailability or limited hours of appointments, high out-of-pocket costs and insurance coverage.

Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through three ...

Basdeo also investigates the innate immune system and how it responds to vaccines. Basedo and her team set off to understand how the BNT162b2 COVID-19 vaccine affected the immune system. This vaccine ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announces a €14,999,998.59 capital increase subscribed by Sanofi.